TrialBlood advances2021

Long-term quality of life of patients with acute promyelocytic leukemia treated with arsenic trioxide vs chemotherapy.

Fabio Efficace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.